Genomic landscape established by allelic imbalance in the cancerization field of a normal appearing airway

Cancer Research

Volumn 76, Issue 13, 2016, Pages 3676-3683

  Jakubek, Yasminka ^a   Lang, Wenhua ^a   Vattathil, Selina ^a,f   Garcia, Melinda ^a,g   Xu, Li ^a   Huang, Lili ^a   Yoo, Suk Young ^a   Shen, Li ^a   Lu, Wei ^a   Chow, Chi Wan ^a   Weber, Zachary ^b   Davies, Gareth ^b   Huang, Jing ^a   Behrens, Carmen ^a   Kalhor, Neda ^a   Moran, Cesar ^a   Fujimoto, Junya ^a   Mehran, Reza ^a   El Zein, Randa ^c   Swisher, Stephen G ^a   Wang, Jing ^a   Fowler, Jerry ^a   Spira, Avrum E ^d   Ehli, Erik A ^b   Wistuba, Ignacio I ^a   Scheet, Paul ^a,e   Kadara, Humam ^a,e   more..

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Avera Health   (United States)

^c HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF TEXAS   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

^g UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELIC IMBALANCE; ARTICLE; CANCER PATIENT; CANCER STAGING; CHEMOPROPHYLAXIS; CHROMOSOME 9; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENOME-WIDE ASSOCIATION STUDY; GENOMICS; HETEROZYGOSITY LOSS; HISTOLOGY; HUMAN; LUNG ADENOCARCINOMA; LUNG CANCER; MALE; NON SMALL CELL LUNG CANCER; PATHOGENESIS; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; SQUAMOUS CELL LUNG CARCINOMA; ADENOCARCINOMA; CASE CONTROL STUDY; CHROMOSOME ABERRATION; COMPARATIVE STUDY; FOLLOW UP; GENETICS; HIGH THROUGHPUT SEQUENCING; HUMAN GENOME; LUNG; LUNG TUMOR; METABOLISM; PATHOLOGY; PROCEDURES; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TUMOR CELL CULTURE; TUMOR RECURRENCE;

TUMOR MARKER;

ADENOCARCINOMA; ALLELIC IMBALANCE; BIOMARKERS, TUMOR; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CHROMOSOME ABERRATIONS; FOLLOW-UP STUDIES; GENOME, HUMAN; GENOMICS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; LUNG; LUNG NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; TUMOR CELLS, CULTURED;

EID: 84977484449     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-15-3064     Document Type: Article

References (25)

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin 2015;65:5-29.
2. Herbst RS, Heymach JV, Lippman SM. Lung cancer. N Engl J Med 2008; 359:1367-80.
3. Novello S, Asamura H, Bazan J, Carbone D, Goldstraw P, Grunenwald D, et al. Early stage lung cancer: progress in the last 40 years. J Thorac Oncol 2014;9:1434-42.
4. Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395-409.
5. Kadara H, Wistuba II. Field cancerization in non-small cell lung cancer: implications in disease pathogenesis. Proc Am Thorac Soc 2012;9:38-42.
6. Wistuba II, Behrens C, Milchgrub S, Bryant D, Hung J, Minna JD, et al. Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma. Oncogene 1999;18:643-50.
7. Belinsky SA, Nikula KJ, Palmisano WA, Michels R, Saccomanno G Gabrielson E, et al. Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis. Proc Natl Acad Sci U S A 1998;95:11891-6.
8. Tang X, Shigematsu H, Bekele BN, Roth JA, Minna JD, Hong WK, et al. EGFR tyrosine kinase domain mutations are detected in histologically normal respiratory epithelium in lung cancer patients. Cancer Res 2005;65:7568-72.
9. Nelson MA, Wymer J, Clements N Jr. Detection of K-ras gene mutations in non-neoplastic lung tissue and lung cancers. Cancer Lett 1996;103:115-21.
10. Kadara H, Fujimoto J, Yoo SY, Maki Y, Gower AC, Kabbout M, et al. Transcriptomic architecture of the adjacent airway field cancerization in non-small cell lung cancer. J Natl Cancer Inst 2014;106:dju004.
11. Biesecker LG, Spinner NB. A genomic view of mosaicism and human disease. Nat Rev Genet 2013;14:307-20.
12. Spitz MR, Hong WK, Amos CI, Wu X, Schabath MB, Dong Q, et al. A risk model for prediction of lung cancer. J Natl Cancer Inst 2007;99:715-26.
13. Kadara H, Shen L, Fujimoto J, Saintigny P, Chow CW, Lang W, et al. Characterizing the molecular spatial and temporal field of injury in earlystage smoker non-small cell lung cancer patients after definitive surgery by expression profiling. Cancer Prev Res 2013;6:8-17.
14. Vattathil S, Scheet P. Haplotype-based profiling of subtle allelic imbalance with SNP arrays. Genome Res 2013;23:152-8.
15. Scheet P, Stephens M. A fast and flexible statistical model for large-scale population genotype data: applications to inferringmissing genotypes and haplotypic phase. Am J Hum Genet 2006;78:629-44.
16. Staaf J, Lindgren D, Vallon-Christersson J, Isaksson A, Goransson H, Juliusson G, et al. Segmentation-based detection of allelic imbalance and loss-of-heterozygosity in cancer cells using whole genome SNP arrays. Genome Biol 2008;9:R136.
17. Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA Jr, Kinzler KW. Cancer genome landscapes. Science 2013;339:1546-58.
18. Wistuba II, Gazdar AF. Lung cancer preneoplasia. Annu Rev Pathol 2006;1:331-48.
19. Weir BA, Woo MS, Getz G, Perner S, Ding L, Beroukhim R, et al. Characterizing the cancer genome in lung adenocarcinoma. Nature 2007;450: 893-8.
20. Bass AJ, Watanabe H, Mermel CH, Yu S, Perner S, Verhaak RG, et al. SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. Nat Genet 2009;41:1238-42.
21. McCaughan F, Pole JC, Bankier AT, Konfortov BA, Carroll B, Falzon M, et al. Progressive 3q amplification consistently targets SOX2 in preinvasive squamous lung cancer. Am J Respir Crit Care Med 2010;182: 83-91.
22. Staaf J, Isaksson S, Karlsson A, Jonsson M, Johansson L, Jonsson P, et al. Landscape of somatic allelic imbalances and copy number alterations in human lung carcinoma. Int J Cancer 2013; 132:2020-31.
23. Gesthalter YB, Vick J, Steiling K, Spira A. Translating the transcriptome into tools for the early detection and prevention of lung cancer. Thorax 2015;70:476-81.
24. Silvestri GA, Vachani A, Whitney D, Elashoff M, Porta Smith K, Ferguson JS, et al. A bronchial genomic classifier for the diagnostic evaluation of lung cancer. N Engl J Med 2015;373:243-51.
25. Spira A, Beane JE, Shah V, Steiling K, Liu G, Schembri F, et al. Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer. Nat Med 2007;13:361-6.